Joseph R. Lambert

FDA investigator

Appears on 6 documents from 2009 to 2020, mostly at sites in Nebraska. Most often cites production record review (21 CFR 211.192).

6
Documents on file
14.0
Observations per 483
2009
First seen
2020
Most recent

What they cite most

From 69 observations

Activity by year

2009: 1, 2011: 2, 2013: 1, 2015: 1, 2020: 1

Where

Nebraska 5 · Missouri 1

Is Joseph R. Lambert coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Nebraska Methodist HospitalFeb 8, 2020 · Omaha, Nebraska
483 Essential Pharmacy Compounding LLCJul 23, 2015 · Omaha, Nebraska
483 Novartis Consumer HealthFeb 14, 2013 · Lincoln, Nebraska
483 Novartis Consumer Health,Jul 8, 2011 · Lincoln, Nebraska
EIR Novartis Consumer HealthJul 8, 2011 · Lincoln, Nebraska
483 KV PharmaceuticalFeb 2, 2009 · Saint Louis, Missouri

About this profile

What does Joseph R. Lambert inspect?

Joseph R. Lambert appears on 6 documents on file covering 4 sites, mostly in Nebraska.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.198 and 21 CFR 211.194.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Joseph R. Lambert is dated Feb 8, 2020.

FDA Investigator Joseph R. Lambert: 483s & Inspections · FDA Intel